User profiles for M. A. Hallman
Mark A HallmanAssistant Professor, Fox Chase Cancer Center Verified email at fccc.edu Cited by 882 |
Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer
NG Zaorsky, T Shaikh, CT Murphy, MA Hallman… - Cancer treatment …, 2016 - Elsevier
We review radiation therapy (RT) options available for prostate cancer, including external
beam (EBRT; with conventional fractionation, hypofractionation, stereotactic body RT [SBRT]) …
beam (EBRT; with conventional fractionation, hypofractionation, stereotactic body RT [SBRT]) …
Applying artificial intelligence to identify physiomarkers predicting severe sepsis in the PICU
R Kamaleswaran, O Akbilgic, MA Hallman… - Pediatric Critical Care …, 2018 - journals.lww.com
Objectives: We used artificial intelligence to develop a novel algorithm using physiomarkers
to predict the onset of severe sepsis in critically ill children. Design: Observational cohort …
to predict the onset of severe sepsis in critically ill children. Design: Observational cohort …
Diversity of release patterns for jail detainees: implications for public health interventions
…, SD Perez, RM Seals, MA Hallman… - … journal of public …, 2011 - ajph.aphapublications.org
… Hallman and R. Kavasery participated in the drafting and revision of the article. PS Weiss …
Hallman is a medical student. Ryan M. Seals is with the Department of Epidemiology, …
Hallman is a medical student. Ryan M. Seals is with the Department of Epidemiology, …
A phase II trial of risk enabled therapy after initiating neoadjuvant chemotherapy for bladder cancer (RETAIN BLADDER): Interim analysis.
…, R Viterbo, EM Horwitz, MA Hallman… - 2021 - ascopubs.org
397 Background: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by cystectomy
(Cx) or chemoradiation (CRT) is the standard of care for urothelial carcinoma (UC) pts with …
(Cx) or chemoradiation (CRT) is the standard of care for urothelial carcinoma (UC) pts with …
Prostate cancer patients with unmanaged diabetes or receiving insulin experience inferior outcomes and toxicities after treatment with radiation therapy
…, P Sharda, SB Hayes, ML Sobczak, MA Hallman… - Clinical genitourinary …, 2017 - Elsevier
Background The purpose of the study was to determine the effect of type 2 diabetes mellitus
(T2DM) on outcomes and toxicities among men with localized prostate cancer receiving …
(T2DM) on outcomes and toxicities among men with localized prostate cancer receiving …
Long-term patient-reported outcomes from a phase 3 randomized prospective trial of conventional versus hypofractionated radiation therapy for localized prostate …
…, ME Johnson, LS Wang, MA Hallman… - International Journal of …, 2017 - Elsevier
Purpose To assess the long-term quality of life (QoL) outcomes from a phase 3 trial
comparing 2 modes of intensity modulated radiation therapy (IMRT): conventional IMRT (CIMRT) …
comparing 2 modes of intensity modulated radiation therapy (IMRT): conventional IMRT (CIMRT) …
Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cells
…, Y Xie, Z Zhang, DJ Brauner, MA Hallman… - Molecular …, 2008 - ASPET
… All were grown on standard tissue culture plastic, except for WT2, which was grown on
suspension culture plastic (Corning, Acton, MA). Stably transfected cell lines were maintained in …
suspension culture plastic (Corning, Acton, MA). Stably transfected cell lines were maintained in …
[HTML][HTML] Ten-year update of a randomized, prospective trial of conventional fractionated versus moderate hypofractionated radiation therapy for localized prostate …
V Avkshtol, KJ Ruth, EA Ross, MA Hallman… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
PURPOSE The previously published single institution randomized prospective trial failed to
show superiority in the 5-year biochemical and/or clinical disease failure (BCDF) rate with …
show superiority in the 5-year biochemical and/or clinical disease failure (BCDF) rate with …
A phase II trial of risk-enabled therapy after initiating neoadjuvant chemotherapy for bladder cancer (RETAIN).
…, R Viterbo, EM Horwitz, MA Hallman… - 2023 - ascopubs.org
438 Background: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by cystectomy
or chemoradiation is the standard of care for urothelial carcinoma (UC) patients with MIBC. …
or chemoradiation is the standard of care for urothelial carcinoma (UC) patients with MIBC. …
Regulation of dedifferentiation and redifferentiation in renal proximal tubular cells by the epidermal growth factor receptor
MA Hallman, S Zhuang, RG Schnellmann - Journal of Pharmacology and …, 2008 - ASPET
Repair of injured renal epithelium is thought to be mediated by surviving renal proximal tubular
cells (RPTC) that must dedifferentiate to allow the proliferation and migration necessary …
cells (RPTC) that must dedifferentiate to allow the proliferation and migration necessary …